Chances of surviving a deadly avian flu pandemic would likely increase with hands-on therapy, even without antiviral drugs, a U.S. health newsletter says.

Nanogen, Inc. (Nasdaq: NGEN), developer of in vitro diagnostic products, announced today it has been awarded a new $10.4 million, two-year contract from the U.S. Centers for Disease Control and Prevention (CDC) to develop a multi-analyte molecular diagnostic assay for Influenza.

Text of report in English by official Chinese news agency Xinhua (New China News Agency) HONG KONG, March 7 (Xinhua) - More than 300 people from government departments, the Hong Kong International Airport and airline held an exercise against avian influenza here Friday as a dead bird was later test positive for the deadly H5N1 strain of virus.

A vaccine against the most common and deadliest strain of avian flu, H5N1, has been tested by researchers at the University of Pittsburgh's Center for Vaccine Research. According to a study published by the Public Library of Science in the Jan.

University of Pittsburgh researchers have started human testing of an avian flu vaccine that protects mice against the deadliest and most common strain of the virus, officials announced Tuesday.